IS5742A - Aðferð til genalækninga - Google Patents

Aðferð til genalækninga

Info

Publication number
IS5742A
IS5742A IS5742A IS5742A IS5742A IS 5742 A IS5742 A IS 5742A IS 5742 A IS5742 A IS 5742A IS 5742 A IS5742 A IS 5742A IS 5742 A IS5742 A IS 5742A
Authority
IS
Iceland
Prior art keywords
gene therapy
therapy
gene
Prior art date
Application number
IS5742A
Other languages
English (en)
Inventor
Braddock Martin
Jeffrey Campbell Callum
Schwachtgen Jean-Luc
Original Assignee
Glaxo Group Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9811836.7A external-priority patent/GB9811836D0/en
Priority claimed from GBGB9815035.2A external-priority patent/GB9815035D0/en
Priority claimed from GBGB9819846.8A external-priority patent/GB9819846D0/en
Priority claimed from GBGB9828578.6A external-priority patent/GB9828578D0/en
Application filed by Glaxo Group Limited filed Critical Glaxo Group Limited
Publication of IS5742A publication Critical patent/IS5742A/is

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/02Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702Regulators; Modulating activity
    • C07K14/4705Regulators; Modulating activity stimulating, promoting or activating activity
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Genetics & Genomics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Toxicology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Immunology (AREA)
  • Dermatology (AREA)
  • Biotechnology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
IS5742A 1998-06-02 2000-11-28 Aðferð til genalækninga IS5742A (is)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
GBGB9811836.7A GB9811836D0 (en) 1998-06-02 1998-06-02 Gene therapy method
GBGB9815035.2A GB9815035D0 (en) 1998-07-11 1998-07-11 Gene therapy method
GBGB9819846.8A GB9819846D0 (en) 1998-09-12 1998-09-12 Gene therapy method
GBGB9828578.6A GB9828578D0 (en) 1998-12-23 1998-12-23 Regulation
PCT/GB1999/001722 WO1999062561A2 (en) 1998-06-02 1999-06-02 Gene therapy method

Publications (1)

Publication Number Publication Date
IS5742A true IS5742A (is) 2000-11-28

Family

ID=27451790

Family Applications (1)

Application Number Title Priority Date Filing Date
IS5742A IS5742A (is) 1998-06-02 2000-11-28 Aðferð til genalækninga

Country Status (29)

Country Link
US (1) US6689758B1 (is)
EP (2) EP1281763A3 (is)
JP (1) JP2002516676A (is)
KR (1) KR20010043968A (is)
CN (1) CN1311822A (is)
AP (1) AP2000001999A0 (is)
AT (1) ATE246518T1 (is)
AU (1) AU770497B2 (is)
BR (1) BR9910877A (is)
CA (1) CA2334171A1 (is)
DE (1) DE69910202T2 (is)
DK (1) DK1083934T3 (is)
EA (1) EA200001124A1 (is)
EE (1) EE200000790A (is)
ES (1) ES2205830T3 (is)
HK (1) HK1034465A1 (is)
HR (1) HRP20000832A2 (is)
HU (1) HUP0103252A3 (is)
ID (1) ID27483A (is)
IL (1) IL139936A0 (is)
IS (1) IS5742A (is)
NO (1) NO20006047L (is)
NZ (1) NZ508505A (is)
PL (1) PL345207A1 (is)
PT (1) PT1083934E (is)
SK (1) SK18322000A3 (is)
TR (2) TR200100348T2 (is)
WO (1) WO1999062561A2 (is)
YU (1) YU75600A (is)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9928430D0 (en) * 1999-12-01 2000-01-26 Glaxo Group Ltd Screening
EP1467207B1 (en) * 2002-01-10 2008-06-04 Takeda Pharmaceutical Company Limited Screening method for a prophylactic and therapeutic substance for a renal disease.
CA2511315A1 (en) * 2002-12-31 2004-07-22 The Johns Hopkins University Wound healing method and kits
WO2005021045A1 (ja) * 2003-08-29 2005-03-10 Anges Mg, Inc. 針無注射器を用いた皮膚疾患の遺伝子治療
DE10342071B4 (de) * 2003-09-10 2006-01-19 Fleischmann, Wilhelm, Dr.med. Vorrichtung und Verfahren zur Applikation von Wïrkstoffen an eine Wundoberfläche
KR100647490B1 (ko) 2004-10-04 2006-11-23 사회복지법인 삼성생명공익재단 저산소 조건 및 다른 스트레스에 특이적으로 반응할 수있는 키메라 인핸서 요소를 포함하는 벡터, 상기 벡터를포함하는 약제학적 조성물 및 상기 조성물을 이용하는 방법
PL2158316T3 (pl) 2007-05-11 2015-10-30 Adynxx Inc Ekspresja genowa oraz ból
FR2920158B1 (fr) * 2007-08-24 2010-03-12 Centre Nat Rech Scient Production de plasmides et expression de proteines recombinantes dans des cellules cultivees sans antibiotiques
FR2924128A1 (fr) * 2007-11-26 2009-05-29 Galderma Res & Dev Modulateurs de egr1 dans le traitement de l'alopecie
BR112012000865A2 (pt) 2009-07-17 2019-09-24 T Tabor Aaron "composição e método para a modificação genética cosmética de células substancialmente intactas"
CN102552938A (zh) * 2012-03-22 2012-07-11 南京大学 Egr-1拮抗剂在制备治疗Ⅱ型糖尿病的药物中的用途
EP2846839B1 (en) 2012-05-10 2019-02-20 Adynxx, Inc. Formulations for the delivery of active ingredients
CA2957250A1 (en) 2014-08-15 2016-02-18 Adynxx, Inc. Oligonucleotide decoys for the treatment of pain
KR101721228B1 (ko) * 2015-04-03 2017-03-30 사회복지법인 삼성생명공익재단 지방유래 줄기세포의 배양액을 유효성분으로 포함하는 발모촉진용 조성물
CN104857529A (zh) * 2015-05-20 2015-08-26 山西大学 Egr-1基因在制备抗膀胱癌药物中的应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5206152A (en) 1988-04-08 1993-04-27 Arch Development Corporation Cloning and expression of early growth regulatory protein genes
US5763209A (en) 1988-09-26 1998-06-09 Arch Development Corporation Methods and materials relating to the functional domains of DNA binding proteins
AUPN855496A0 (en) 1996-03-07 1996-04-04 Unisearch Limited Prevention of proliferation of vascular cells

Also Published As

Publication number Publication date
EP1083934A2 (en) 2001-03-21
ES2205830T3 (es) 2004-05-01
EE200000790A (et) 2002-04-15
ATE246518T1 (de) 2003-08-15
CA2334171A1 (en) 1999-12-09
DE69910202T2 (de) 2004-06-17
WO1999062561A2 (en) 1999-12-09
NZ508505A (en) 2003-04-29
IL139936A0 (en) 2002-02-10
ID27483A (id) 2001-04-12
DK1083934T3 (da) 2003-12-01
HRP20000832A2 (en) 2001-04-30
PL345207A1 (en) 2001-12-03
TR200102985T2 (tr) 2002-06-21
WO1999062561A3 (en) 2000-08-03
HUP0103252A3 (en) 2003-09-29
SK18322000A3 (sk) 2001-11-06
BR9910877A (pt) 2002-01-22
CN1311822A (zh) 2001-09-05
HK1034465A1 (en) 2001-10-26
NO20006047D0 (no) 2000-11-29
EP1281763A3 (en) 2003-07-09
EP1083934B1 (en) 2003-08-06
NO20006047L (no) 2001-02-01
AU770497B2 (en) 2004-02-26
KR20010043968A (ko) 2001-05-25
EP1281763A2 (en) 2003-02-05
EA200001124A1 (ru) 2001-08-27
YU75600A (sh) 2004-03-12
US6689758B1 (en) 2004-02-10
PT1083934E (pt) 2003-12-31
DE69910202D1 (de) 2003-09-11
AU4156099A (en) 1999-12-20
TR200100348T2 (tr) 2001-07-23
HUP0103252A2 (hu) 2001-12-28
JP2002516676A (ja) 2002-06-11
AP2000001999A0 (en) 2000-12-31

Similar Documents

Publication Publication Date Title
DK1121192T3 (da) Fremgangsmåde til homogenisering
EE9900357A (et) Geenisekvenaator ja meetodid
ID26990A (id) Metode pembuatan dimetilnaftalena
IS5742A (is) Aðferð til genalækninga
NO986177D0 (no) FremgangsmÕte for fremstilling av terapeutisk DNA
DK0987356T3 (da) Fremgangsmåde til trækning
DK0874822T3 (da) Ny fremgangsmåde til fremstilling
ID19540A (id) Metode pembuatan turunan-turunan benzofenon
DK1117421T3 (da) Hidtil ukendte fremgangsmåder til terapuetisk vaccination
ID23019A (id) Metode pembuatan turunan nitroguadinin
UA25504A (uk) Спосіб лікуваhhя дисбактеріозу hосоглотки
UA27992C2 (uk) Спосіб лікування онкологічних захворювань
ID23446A (id) Metode pembuatan turunan 2-nitroguanidin tersubstitusi
UA25260A (uk) Спосіб отримаhhя 2-феhіл-3-карбетокси-5-гідроксибеhзофураhу
UA26025C2 (uk) Спосіб одержаhhя портлаhдцемеhтhого кліhкеру
SE9803550D0 (sv) Method of application
SE9802223D0 (sv) Method of application
IS5048A (is) Aðferð til lyfjagreiningar
NO972178D0 (no) Fremgangsmåte til nedregulering av genekspresjon
IT1294014B1 (it) Metodo di applicazione per fangoterapia
IT1296993B1 (it) Metodo di trattamento di oociti
UA25674A (uk) Спосіб лікуваhhя раку легеhь
UA25577A (uk) Спосіб обробки голиhи
UA25636A (uk) Спосіб лікуваhhя hеврозів
UA33970A (uk) Спосіб лікування періодонтиту